Kolon TissueGene, Inc. (KOSDAQ:950160)

Kolon TissueGene Revenue

In the year 2025, Kolon TissueGene had annual revenue of 5.16B KRW with 1.68% growth. Kolon TissueGene had revenue of 860.82M in the quarter ending December 31, 2025, with 10.50% growth.

• Revenue: 5.16B
• Revenue Growth: +1.68%
• P/S Ratio: 1,662.29
• Revenue / Employee: 177.89M
• Employees: 29
• Market Cap: 8.58T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.16B	85.27M	1.68%
Dec 31, 2024	5.07B	1.37B	36.90%
Dec 31, 2023	3.71B	-5.75B	-60.81%
Dec 31, 2022	9.46B	5.45B	136.22%
Dec 31, 2021	4.00B	447.31M	12.58%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 16, 2026

Data Sources Report a data error